Post-earnings recap
Reported
Wed, Aug 3, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad Laboratories reported a significant miss on EPS, which contributed to a slight decline in stock price. The management's defensive tone suggests they are aware of the challenges ahead but are focused on improving operations. Investors may need to watch for further developments as the company navigates these issues.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | -46.02% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current market conditions impacting performance. They are looking for ways to enhance efficiency and adapt to challenges.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on improving operational efficiency moving forward.